| 直肠癌新辅助治疗后病理降期相关研究进展 |
| |
| 引用本文： | 丁叔波. 直肠癌新辅助治疗后病理降期相关研究进展[J]. 国际肿瘤学杂志, 2009, 36(11). DOI: 10.3760/cma.j.jssn.1673-422X.2009.11.020 |
| |
| 作者姓名： | 丁叔波 |
| |
| 作者单位： | 浙江中医药大学内科学,杭州,310022 |
| |
| 摘 要： | 术前同步放化疗已成为局部晚期直肠癌的标准治疗模式.新辅助治疗后病理降期与直肠癌预后关系密切,找到能预测直肠癌新辅助治疗病理降期标记,有着重要的临床意义.不同放化疗方案、靶向药物在新辅助治疗中的应用、新辅助治疗后至手术间隔时间与病理降期相关.
|
| 关 键 词： | 直肠肿瘤 化学疗法 辅助 放射疗法 病理降期 |
Histopathological regression after preoperative chemoradiotherapy in locally advanced rectal carcinoma |
| |
| DING Shu-bo. Histopathological regression after preoperative chemoradiotherapy in locally advanced rectal carcinoma[J]. Journal of International Oncology, 2009, 36(11). DOI: 10.3760/cma.j.jssn.1673-422X.2009.11.020 |
| |
| Authors: | DING Shu-bo |
| |
| Abstract: | Neoadjuvant chemoradiotherapy (CRT) has become a standard treatment of locally advanced rectal carcinomas. There is a close correlation between histopathological regression after preoperative CRT and prognosis. To identify the markers for histopathological regression is significant for clinical treatment. Different strategies of chemoradiotherapy, application of targeted drugs in neoadjuvant chemothercepy and internal from neoodjuvant to operation are correlated with histopathological regression. |
| |
| Keywords: | Rectal neoplasms Chemotherapy,adjuvant Radiotherapy,adjuvant Histopathological regression |
| 本文献已被 万方数据 等数据库收录！ |
|
